Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Association Between Pre-operative Pain Psychology and Hypersensitivity With Poor Functional Outcome After Knee Replacement.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03132064
Recruitment Status : Suspended (COVID-19)
First Posted : April 27, 2017
Last Update Posted : May 27, 2020
Sponsor:
Collaborator:
Stockport NHS Foundation Trust
Information provided by (Responsible Party):
Bodor Bin sheeha, University of Salford

Brief Summary:

To explore whether there are factors that help us to understand why some patient outcomes are not successful and identify prediction factors for progression. Assess central pain sensitisation and psychology pre- and post-surgery with reliable tools that explore prediction tools for good/poor progression and improve patient selection, patient preparation and timing for surgery.

The aim of this project is to explore the effects of pre-surgical central pain sensitisation on pain and function outcomes post-TKA. Central pain sensitisation will be assessed using pressure algometry and the Pain Catastrophizing Scale will be used to explore pain psychology. Functional outcomes post-TKA will be assessed using a commonly used scale for patients' self-reported outcomes (Oxford Knee Score), visual analogue scale, a star excursion balance test and four recommended patient performance-based tests.


Condition or disease Intervention/treatment
Outcome After Total Knee Arthroplasty Procedure: total knee arthroplasty

Show Show detailed description

Layout table for study information
Study Type : Observational
Estimated Enrollment : 50 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Association Between Pre-operative Pain Psychology and Hypersensitivity With Poor Functional Outcome After Knee Replacement
Estimated Study Start Date : September 12, 2020
Estimated Primary Completion Date : February 1, 2022
Estimated Study Completion Date : December 1, 2022

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
post total knee arthroplasty
The measurements will made for patients before and after total knee arthroplasty to explore the improvements and possible correlation with preoperative pain psychology and hypersensitivity
Procedure: total knee arthroplasty
surgical repair for end stage of knee osteoarthritis.
Other Name: total knee replacement surgery




Primary Outcome Measures :
  1. Changes in Pain Catastrophizing Scale (PCS) [ Time Frame: before surgery and 6 months after ]

    Catastrophizing contributes to heightened levels of pain, emotional distress, chronic pain and disability (Forsythe, Dunbar, Hennigar, Sullivan, & Gross, 2008).

    The PCS has 13 items and can be completed and scored in less than 5 minutes. It reflects past painful experiences and indicates the degree to which patients experience each of 13 thoughts or feelings when in pain. It has 5-point scales with end points (0) not at all and (4) all the time. Between the 50th and 75th percentiles of PCS score, patients are considered at moderate risk and at more than the 75th percentile they are consider at high risk for developing chronicity. It is a reliable and valid catastrophizing measure, it shows excellent internal consistency, total score coefficient alphas = .87-.93 and significant correlation with the Inventory of Negative Thoughts in Response to Pain scale and general psychological disturbance (MASQGeneral Disturbance) scale (Osman et al., 1997; Sullivan & et al., 1995) (Appendix 3).


  2. Changes in Central Sensitisation using pressure algometry [ Time Frame: before surgery and 6 months after ]
    Pressure will be applied using a handheld pressure algometer (Algometer Type II, Somedic AB, Sweden) at a rate of 30 kPa/s perpendicular to the skin with a 1 cm² probe. The pressure pain threshold will be estimated by instructing participants to say 'stop' when the sensation of pressure becomes the first sensation of pain (Arendt-Nielsen et al., 2010; Lunn, Kristensen, Gaarn-Larsen, & Kehlet, 2012; Skou et al., 2013). Pressure will be applied to the medial side of the operated knee and the volar surface of the same side forearm. These two body sites are chosen because they represent painful areas in knee OA patients and may provide evidence of widespread pain sensitisation (forearm) and localised pain sensitisation (knee) (Wylde, Palmer, Learmonth, & Dieppe, 2011; Wylde et al., 2013). The site for knee pressure will be at 3 cm medial to the midpoint on the medial edge of the index patella


Secondary Outcome Measures :
  1. Changes in Oxford Knee Score (OKS) [ Time Frame: before surgery and 6 months after ]

    A final version of a 12-item questionnaire was developed to assess patients post-TKA after interviews with patients undergoing joint replacement and a multiple drafting process to identify their experiences and problems post-TKA since 1998 (Appendix 4).

    OKS is a valid, reliable and responsive assessment tool for the period post-TKA, it has advantages over the Western Ontario and McMaster Universities Osteoarthritis Index - Knee Injury and Osteoarthritis Outcome Score, as it simple and short. As a PROM's main concern is to explore outcomes from the patient's perspective, OKS has the advantage of offering clear MIDC values for all types of study and is designed to ensure that results are recognized by patients, in addition to statistical differences, and this may improve the power calculation (Beard et al., 2015; Clement, MacDonald, Patton, & Burnett, 2015; Clement, MacDonald, & Simpson, 2014; Dawson, Fitzpatrick, Murray, & Carr, 1998)


  2. Changes in pain visual analogue scale (VAS); [ Time Frame: before surgery and 6 months after ]
    The pain visual analogue scale will used to assess the pain before and after the surgery. The scale consist of a 100 mm long horizontal line ranging from no pain to intolerable pain (Appendix 4). Patients will instruct to mark the line at the point matched their pain. The assessor will measure with ruler the millimetres and converted to points (0 points no pain to 100 points intolerable pain) (Bullens, van Loon, de Waal Malefijt, Laan, & Veth, 2001).

  3. Changes in Assessment of Performance based measurements (30 s chair-stand test) [ Time Frame: before surgery and 6 months after ]
    Based in published protocol, the chair with 17 inches (45cm) height with starting position will be sitting with arm cross the chest. The patients will instruct to stand then sit with good buttock placement, back support, hand on arm rest and foot placements then stand again as fast and safe as they can. The assessor will count the number of complete chair stand within the 30 second. The mean of two trail will use for analysis (Gill & McBurney, 2008; Unver, Kalkan, Yuksel, Kahraman, & Karatosun, 2015).

  4. Changes in stair-climb test [ Time Frame: before surgery and 6 months after ]
    The assessor will measure the time required using timed stopwatch within one hundredth of second using one handrail if required to ascend and descend flight of twelve 18-cm-high steps and 28 cm depth. The patients will instruct to ascend and descend the stairs as quickly, safe and comfortable they can. The mean of two trail will use for analysis (Mizner et al., 2011).

  5. Changes in Timed up-and-go test [ Time Frame: before surgery and 6 months after ]
    According to published protocol the test procedure will be as following based on used timed stopwatch within one hundredth of second, standard height chair of 45cm with arm rest will placed on an outdoor level footpath and a line 3 meters from the chair will draw. The patients will instruct to rise from chair using the arms if required, walk for 3 meter until the line mark then turn back to sit on the chair as quickly, safe and comfortable they can. The assessor commenced timing as the patient leaned forward to stand up, and stop when the patient hips made contact with the seat to sit down. Average of 3 performance will analysis (Ko, Naylor, Harris, Crosbie, & Yeo, 2013; Mizner et al., 2011; Podsiadlo & Richardson, 1991).

  6. Changes in Six minute walk test [ Time Frame: before surgery and 6 months after ]
    Based on the test published guideline the test will measure how far the patients can walk in 6 minute in level surface, 25 meter footpath. The patient can use the assistive device if required, take rest if need with standardized encouragement after each minute. The assessor will ask the patient to stop at 6 minute. One test will be perform to avoid fatigue ("ATS Statement," 2002; Ko et al., 2013; Mizner et al., 2011).

  7. Changes in Balance Test [ Time Frame: before surgery and 6 months after ]
    Balance will be assessed using the simple Star Excursion Balance Test, which is considered to be a reliable, valid dynamic test to identify dynamic balance deficits in patients with lower extremity conditions. The assessor will measure the reach distance in each direction in centimetres and then normalise the average of the three trials to leg length. Limb length will be measured while lying in a supine position from anterior superior iliac spine to the centre of the ipsilateral medial malleolus. Reach distances will be normalised to limb length by calculating the maximum reach distance (%MAXD) using the formula (excursion distance/limb length) ×100 (Coughlan, Fullam, Delahunt, Gissane, & Caulfield, 2012; Fullam et al., 2014; Robinson & Gribble, 2008).

  8. Changes in Physical activity [ Time Frame: before surgery and 6 months after ]
    measurements will be made using an activPAL activity monitor (PAL Technologies, Glasgow, UK) as this proven accelerometer provides objective quantification of free-living physical activity without any modification (Dahlgren, Carlsson, Moorhead, Hager-Ross, & McDonough, 2010; Schmalzried et al., 1998). It is suitable as it light in weight (20g), includes an inclinometer and is small in size (53 x 35 x 7 mm) Figure 3. The device is worn by patient's mid-thigh, secured by non-allergic waterproof adhesive tape under their clothes, for 7-10 days before surgery and 6 months after. Clear written and verbal instructions will be given to patients as they have to wear it all day and all night except, when bathing or swimming (they can take a shower with it on).



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Sampling Method:   Probability Sample
Study Population
The present study is a prospective randomised 6 months follow-up. All patients scheduled for elective primary unilateral total knee arthroplasty for end-stage knee osteoarthritis with stable and controlled medical condition will asked for participation in preadmission orthopaedics clinic visit at Stepping Hill Hospital. The information sheet will give to all participants agreed to participate to clarify the objective of study (Appendix 1). Before commencement, patients will sign a consent form (Appendix 2) and have the right to clarify any enquiry regarding the study with the researcher. The patient's participation will not affect the quality of service, all patients will received conventional orthopaedic care and a standard amount of physiotherapy according to hospital protocols.
Criteria

Inclusion Criteria:

  • All patients scheduled for elective primary unilateral total knee arthroplasty for end-stage knee osteoarthritis with stable and controlled medical condition

Exclusion Criteria:

Potential research participants were excluded from the study if ;

  • The patients schedule for bilateral knee arthroplasty or unilateral knee revision surgery.
  • The patient cannot read and understand English language.
  • Their function limited due to other musculoskeletal involvements other than unilateral knee osteoarthritis.
  • Diagnosed with uncontrolled diabetes mellitus or blood pressure.
  • Diagnosed with any neurologic disorders such as stroke, Parkinson disease or multiple sclerosis.
  • morbid obese patients their body mass index BMI greater than 40.
  • Advance osteoporosis or other unstable chronic disease.
  • Diagnosed with peripheral vascular diseases or uncontrolled cardiac diseases.
  • The participant will excluded post-surgery if they develop any surgical complication such as deep vein thrombosis, uncontrolled infection, or fracture

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03132064


Locations
Layout table for location information
United Kingdom
Stockport NHS Foundation Trust
Stockport, Manchester, United Kingdom, SK2 7JE
Sponsors and Collaborators
University of Salford
Stockport NHS Foundation Trust
Publications:
Sullivan, M. J. L., & et al. (1995). The Pain Catastrophizing Scale: Development and Validation. Psychological Assessment, 7(4), 524-532.

Layout table for additonal information
Responsible Party: Bodor Bin sheeha, Principal Investigator -PhD student at University of Salford, University of Salford
ClinicalTrials.gov Identifier: NCT03132064    
Other Study ID Numbers: usalford- prospective
First Posted: April 27, 2017    Key Record Dates
Last Update Posted: May 27, 2020
Last Verified: May 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Hypersensitivity
Immune System Diseases